VRTX
VERTEX PHARMACEUTICALS INC / MA
NASDAQ · Healthcare · Biotechnology · US
$501.95
+0.44%Forward multiples
Based on analyst estimates
- P/E forward
- 25.26x
- P/E 2026E
- 26.98x
- P/E 2027E
- 23.94x
- P/E 2028E
- 20.03x
- P/S forward
- 8.94x
Trailing multiples
Trailing twelve months
- P/E TTM
- 28.98x
- PEG TTM
- 1.98x
- Price / book
- 6.28x
- Price / sales
- 10.08x
- Price / cash flow
- 29.64x
Enterprise value
- Enterprise value
- $121.3B
- EV / sales
- 9.61x
- EV / EBITDA
- 22.05x
- EV / EBIT
- 24.91x
- Market cap
- $127.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026